What is The Procter & Gamble's gross profit margin?

What factors drove the changes in The Procter & Gamble's revenue and profit?

What guidance did The Procter & Gamble's management provide for the next earnings period?

What does The Procter & Gamble do and what are its main business segments?

Did The Procter & Gamble beat or miss consensus estimates last quarter?

What is the revenue and EPS growth rate for The Procter & Gamble year over year?

What is The Procter & Gamble's latest dividend and current dividend yield?

What were the key takeaways from The Procter & Gamble's earnings call?

- **Global Growth Momentum**: 3% organic growth outside U.S., led by Latin America (8%), China (3%), and Europe (1%).
- **Innovation Success**: Pampers Prestige (China) and Downy Intense (Mexico) drive double-digit growth.
- **U.S. Recovery Plan**: New products (Tide evo, Olay) and sharper execution to offset base-period inventory headwinds.
- **Financial Resilience**: Core EPS $1.88, 88% free cash flow productivity, and FY26 guidance for 0-4% growth across metrics.
- **Strategic Focus**: Reinventing P&G through data, AI, and consumer-centric innovation to create superior value.

**【CEO Summary Section】**
- Organic sales growth of 3% outside the U.S., driven by Latin America (8%), Greater China (3%), and Europe (1%).
- Key innovations: Pampers Prestige in China (double-digit growth), Downy Intense in Mexico (double-digit growth), and Tide Boost in the U.S.
- Focus on consumer-centric innovation, sharper execution, and brand communication to accelerate U.S. recovery.
- Long-term strategy: Reinvent P&G by leveraging data, AI, and supply chain to create superior consumer propositions.

**【CFO Financial Commentary】**
- Q2 organic sales flat YoY, with Family Care down 10% due to base-period inventory impacts.
- Core EPS $1.88, in line with prior year; adjusted free cash flow productivity 88%.
- FY26 guidance: Organic sales growth 0-4%, core EPS 0-4%, and free cash flow productivity 85-90%.
- FY26 outlook includes $500M pre-tax tariffs and $250M after-tax tax headwinds.
- Strong reinvestment of productivity (270bps) in innovation and demand creation.

**【Q&A Highlights】**
- **Near-term confidence**: Strong execution in Latin America, Europe, and China; U.S. recovery driven by new innovations (e.g., Tide evo, Olay launches).
- **Long-term reinvention**: Building data platforms, AI tools, and supply chain 3.0 for consumer-centric growth.
- **U.S. strategy**: Focus on value through product performance (e.g., Tide Boost), media efficiency, and in-store trial.
- **Margins**: Productivity gains (270bps) reinvested in growth; FY26 EPS guidance reflects cautious macro assumptions.
- **Share recovery**: Targeting share growth in U.S. and globally through superior propositions and execution.

The Procter & Gamble Company (PG) Q2 2026 Earnings Call Transcript

- **Topline Growth**: 2% organic sales driven by Latin America (+7%) and China (+5%), despite U.S. category deceleration.
- **Profitability**: Core EPS +3% to $1.99, with 102% free cash flow productivity and $3.8B shareholder returns.
- **Innovation Edge**: Tide evo test-market success, SK-II premium body wash +80% online, and Baby Dry mid-tier expansion.
- **Restructuring Impact**: 7,000 job cuts to enable $1.5B savings; China restructured go-to-market model driving Baby Care +20%.
- **Risks & Tailwinds**: Commodity headwinds reduced to $100M, but Q2 2026 softer due to prior year port strike distortions.

**【CFO Overview】**
- Q1 2026 organic sales growth of 2%, driven by broad-based category performance (8/10 categories grew) and regional strength in Latin America (+7%) and Greater China (+5%).
- Core EPS of $1.99, up 3% YoY, with strong free cash flow productivity (102%) and $3.8B returned to shareholders (dividends + buybacks).
- Global market share down 30bps, but 24/50 category-country combinations held or gained share.

**【Financial Highlights】**
- Core gross margin down 50bps, offset by 230bps productivity gains.
- Adjusted free cash flow of $1.8B, with $10B+ dividends and $5B+ buybacks planned for FY26.
- Commodity headwind reduced to $100M (from $300M), tariff tailwind of $300M, and $500M restructuring costs.

**【Strategy & Innovation】**
- **Product Innovation**: Tide evo (recyclable, no plastic) launched in test markets with strong retailer demand; SK-II premium body wash (+80% online); Pampers Baby Dry mid-tier innovation.
- **Restructuring**: 7,000 non-manufacturing job cuts (15% workforce reduction) to enable $1.5B+ COGS savings; portfolio rationalization (e.g., Pakistan import model, India laundry bar exit).
- **Market Focus**: China restructured go-to-market model, driving 20% Baby Care growth; Latin America Personal HealthCare +15%.

**【Q&A Highlights】**
- **North America Dynamics**: Fabric Care and Baby Care facing competitive promotions; response via innovation (Tide boosted formula, Luvs Platinum value tier).
- **China Recovery**: 5% organic growth driven by SK-II (+12%), Olay premium body wash (+80% online), and Baby Care (+20%).
- **Tariff Impact**: Exemptions for natural ingredients (e.g., psyllium) reduced headwinds; Q2 2026 softer due to prior year port strike distortions.
- **AI & Commerce**: Partnering with OpenAI/Walmart to leverage generative AI for consumer insights and basket optimization.


The Procter & Gamble Company (PG) Q1 2026 Earnings Call Transcript

- **Leadership Transition**: Shailesh Jejurikar to lead with restructuring to streamline operations and drive growth.
- **Financial Performance**: FY25 core EPS $6.83, FY26 guidance 0-4% organic growth, facing $1B tariff headwind.
- **Innovation Success**: Swiffer PowerMop, Tide evo, SK-II LXP deliver category-leading growth.
- **Tariff Mitigation**: Pricing and productivity to offset costs, but consumer confidence critical.
- **China Recovery**: Sequential improvement with innovation-driven Baby Care and SK-II growth.

**【CEO Opening Remarks】**
- Jon Moeller announced his transition to Executive Chairman, with Shailesh Jejurikar becoming CEO, emphasizing a planned leadership succession.
- Highlighted P&G's strategy of balanced top and bottom line growth, focusing on superior product innovation and market share gains.
- Discussed the 2-year restructuring program to streamline portfolio, supply chain, and organization, targeting 7,000 non-manufacturing job reductions.

**【CFO Financial Commentary】**
- FY25 organic sales grew 2%, with North America and Latin America leading at 2% and 4% respectively.
- Core EPS of $6.83, up 4%, driven by productivity improvements and cost control.
- FY26 guidance: organic sales 0-4% growth, core EPS $6.83-$7.09, with $200M tariff headwind and $300M FX tailwind.
- Adjusted free cash flow productivity expected at 85-90%, supporting $15B cash return.

**【CEO Strategy Discussion】**
- Emphasized 5 vectors of innovation: product, package, brand communication, retail execution, and value.
- Examples of successful innovations: Swiffer PowerMop (40% category growth), Tide evo (test market success), SK-II LXP (super-premium segment growth).
- Restructuring aims to create $1.5B gross savings, enabling reinvestment in growth and margin expansion.

**【Q&A Highlights】**
- **Tariff Impact**: FY26 expects $1B tariff headwind, with 50% from China-US trade. Pricing and productivity will mitigate, but consumer confidence is key.
- **U.S. Market**: Inventory destocking in Focus Markets, but online and club channels growing. Consumer trade-down pressure countered by innovation.
- **China Recovery**: Q4 organic sales +2%, driven by 618 event. Innovation in Baby Care and SK-II driving share gains.
- **Restructuring Savings**: $1B pre-tax savings to begin in FY26H2, supporting EPS growth despite headwinds.
- **Consumer Trends**: Slow category growth due to macro uncertainty, but P&G's daily use portfolio resilient.


The Procter & Gamble Company (PG) Q4 2025 Earnings Call Transcript

- **Q3 Growth Resilience**: 1% organic sales vs flat consensus, driven by SK-II (+11%), Oral-B (+50bps share), and broad category hold (7/10 up).
- **FY25 Guidance**: +2% sales, +2-4% EPS. Q4 0.5-4.5% growth range reflects consumer uncertainty.
- **Tariff Mitigation Plan**: $1B-$1.5B impact offset by productivity ($200M+ savings), sourcing, and pricing. 3-year glide path to balance top/bottom line.
- **Innovation Edge**: Tide EVO test market success (+category growth vs premium price), SK-II LXP super-premium growth, Oral-B I-10 premiumization.
- **Shareholder Returns**: $16B-$17B total returns (dividends + buybacks), 90%+ free cash flow productivity.


**【CEO Summary Section】**
- Organic sales grew 1% Q3, with 7 of 10 categories holding or growing. North America and Europe saw modest growth despite consumer volatility. SK-II in China grew double digits on innovation. Global market share held well, with private label share declining in key regions.
- Guidance for FY25: Organic sales +2%, core EPS $6.72-$6.82 (+2-4% vs prior year). Q4 organic growth expected 0.5-4.5%.
- Strategy focus: Maintain innovation pipeline, productivity investments, and long-term category growth despite near-term macro challenges.

**【CFO Financial Commentary】**
- Core EPS $1.54 (+1% YoY), core operating margin +100bps to 16.3%. Adjusted free cash flow productivity 75%, returning $3.8B to shareholders (dividends + buybacks).
- FY25 outlook: Commodity cost headwind $200M, FX headwind $200M, tariffs $100M-$160M Q4. Free cash flow productivity 90%, $16B-$17B total returns (dividends + buybacks).
- Tariff impact FY25: $1B-$1.5B pre-tax, primarily from China imports and U.S. exports to Canada.

**【Strategy & Innovation Highlights】**
- Innovation pipeline strong: Tide EVO, Oral-B I-10, Oxy Boost Fabric Care, SK-II LXP. Test market results exceed expectations (EVO +category growth vs premium pricing).
- Productivity initiatives: 280bps cost savings vs plan, including compensation adjustments. 3-year productivity plan to offset tariffs and inflation.
- Portfolio optimization: Focus on U.S. dollar-based returns in daily use categories. France law implementation annualized, easier comps ahead.

**【Q&A Key Themes】**
- **Consumer Behavior**: U.S. and Europe consumption down 2pts YoY, but P&G share held due to brand superiority. Shift to online/big box/club channels, not trade-down.
- **Tariff Mitigation**: Productivity ($200M+ savings), sourcing flexibility, selective pricing. 12-18mo timeline for full mitigation.
- **China Recovery**: SK-II +11% on LXP innovation, but overall market soft. Pampers, Oral-B, Fabric Care showing progress.
- **Supply Chain Resilience**: 70%+ production near key markets. No plans to shift long-term sourcing due to tariffs.


The Procter & Gamble Company (PG)-24 Apr 25-2025 Q3 Earnings call transcript

- **Topline Resilience**: Q2 organic +3% (North America +4%), FY25 guidance 3-5% despite $0.20 EPS FX/commodity headwinds.
- **China Turnaround**: Q2 down 3% vs. Q1 15% decline, SK-II +5%, core brands gaining share via digital channel expansion.
- **Innovation Edge**: 260bps productivity gains, 3-year cost savings plans, 19/20 quarters with pricing contribution.
- **Cash Return**: $4.9B returned Q2, FY25 target $16-17B ($10B dividends, $6-7B buybacks).

**【CFO Second Quarter Overview】**
- Organic sales grew 3% driven by 2% volume and 1% mix, with North America up 4% on 4% volume growth. 
- Core EPS of $1.88 (+2% YoY) included $0.02 incremental costs from a TMS outage. 
- Adjusted free cash flow productivity was 84%, with $4.9B returned to shareholders ($2.4B dividends, $2.5B buybacks).

**【CEO Strategic Update】**
- 26 consecutive quarters of ≥2% organic sales growth (5.5% avg), 8.5 years of ≥2% core EPS growth (8% avg). 
- Key innovations: Charmin smooth tear (+share), Swiffer PowerMop (+40% brand growth), Tide evo test market success. 
- Productivity improvements of 260bps vs. prior year, 3-year cost savings plans in development.

**【CFO Full Year Guidance】**
- Organic sales: 3-5% growth (3-4% market growth + modest outperformance). 
- Core EPS: $6.91-7.05 (+5-7% vs. $6.59 FY24). 
- Headwinds: $0.08 from commodities, $0.12 from FX, $0.10-12 from lower nonop income/tax. 
- Free cash flow productivity target: 90% ($16-17B total returns).

**【Q&A Key Takeaways】**
- **China Recovery**: Q2 organic down 3% vs. Q1 15% decline, SK-II +5%, core brands gaining share via Douyin investment. 
- **FX Risk**: $0.12 EPS headwind from weaker EUR/GBP, hedging 70% of FY25 exposure. 
- **Innovation Momentum**: 19/20 quarters with pricing contribution, 54/57 quarters with neutral/positive pricing impact.

PG

PG fundamentals

Earnings Call

You can ask Aime